Cannara Biotech Inc. (LOVFF)
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
Cannara Biotech Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 1.44 | 1.44 | 1.44 | 1.44 | 108 |
| Nov 13, 2026 | 1.42 | 1.43 | 1.42 | 1.43 | 7,632 |
| Nov 12, 2026 | 1.40 | 1.41 | 1.40 | 1.40 | 3,300 |
| Nov 11, 2026 | 1.42 | 1.43 | 1.40 | 1.40 | 74,000 |
| Nov 10, 2026 | 1.45 | 1.45 | 1.45 | 1.45 | 100 |
| Nov 9, 2026 | 1.48 | 1.49 | 1.48 | 1.49 | 5,200 |
| Nov 6, 2026 | 1.44 | 1.55 | 1.44 | 1.52 | 64,425 |
| Nov 5, 2026 | 1.51 | 1.51 | 1.51 | 1.51 | 1,500 |
| Nov 2, 2026 | 1.45 | 1.45 | 1.45 | 1.45 | 3,000 |
| Oct 28, 2026 | 1.41 | 1.43 | 1.41 | 1.43 | 2,600 |
| Oct 27, 2026 | 1.43 | 1.43 | 1.43 | 1.43 | 1,000 |
| Oct 21, 2026 | 1.44 | 1.44 | 1.44 | 1.44 | 7,500 |
| Oct 20, 2026 | 1.44 | 1.44 | 1.44 | 1.44 | 100 |
| Oct 16, 2026 | 1.43 | 1.47 | 1.41 | 1.47 | 3,300 |
| Oct 15, 2026 | 1.46 | 1.46 | 1.45 | 1.45 | 9,250 |
| Oct 14, 2026 | 1.47 | 1.47 | 1.47 | 1.47 | 300 |
| Oct 13, 2026 | 1.48 | 1.48 | 1.48 | 1.48 | 700 |
| Oct 9, 2026 | 1.50 | 1.50 | 1.50 | 1.50 | 1,524 |
| Oct 8, 2026 | 1.51 | 1.51 | 1.51 | 1.51 | 202 |
| Oct 7, 2026 | 1.51 | 1.51 | 1.51 | 1.51 | 200 |
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada.
The company operates in two segment Cannabis operations and Real estate operations.
It offers its products under TRIBAL, nugz, and ORCHID CBD brand name.
The company sells its products through wholesalers and online merchandisers.
In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
based on 97.85M shares outstanding
30d Avg
13.11K
60d Avg
12.55K
90d Avg
10.01K
Cannara Biotech Inc. (OTC: LOVFF) traded at $1.44 on Nov 16, 2026, up 0.42% from the previous close of $1.43. 52-week range: $1.11 to $1.66. The company is in the Healthcare sector (Drug Manufacturers - Specialty & Generic).